Physician profile
Gregory A Buser
NPI 1548280407
$2,374.43
in general payments reported to CMS, 2019-2025
17 companies · $1,008 in 2025
The $1,008 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $209 · 2021: $98.92 · 2022: $332 · 2023: $235 · 2024: $88.05 · 2025: $1,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $675 · Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $674.94 |
| Food and Beverage | $655.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,297.86 | 2019-2025 | Aveir, Assurity, Perclose Prostyle |
| Medtronic Vascular, INC. | $390.97 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $133.55 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $121.06 | 2022-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $93.06 | 2019-2025 | |
| Irhythm Technologies, INC. | $56.70 | 2022-2023 | Zio Xt Patch |
| Boston Scientific Corporation | $47.74 | 2021-2023 | Therasphere Y90 Glass Microspheres 10 Gbq, Lux-Dx Insertable Cardiac Monitor |
| Abiomed | $42.63 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $40.06 | 2020-2022 | |
| Depuy Synthes Sales INC. | $33.17 | 2022 | |
| Shockwave Medical, INC | $27.38 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $22.93 | 2022 | |
| Medtronic, INC. | $15.53 | 2022 | |
| Merck Sharp & Dohme LLC | $14.21 | 2021 | |
| Sanofi-Aventis U.S. LLC | $12.76 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 | |
| Novo Nordisk INC | $12.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Buser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.